Fuji Pharma Co., Ltd. (TYO:4554)
Japan · Delayed Price · Currency is JPY 2,295.00
-39.00 (-1.67%)
Jun 19, 2026, 3:30 PM JST
Fuji Pharma Market Cap
Fuji Pharma has a market cap or net worth of 59.94 billion as of June 18, 2026. Its market cap has increased by 92.32% in one year.
Market Cap
59.94B
Enterprise Value
78.68B
Revenue
57.30B
Ranking
n/a
PE Ratio
23.29
Stock Price
2,295.00
Market Cap Chart
Since December 21, 2005, Fuji Pharma's market cap has increased from 17.38B to 59.94B, an increase of 244.82%. That is a compound annual growth rate of 6.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 59.94B | 29.83% |
| Dec 30, 2025 | 46.17B | 18.77% |
| Dec 30, 2024 | 38.88B | -8.01% |
| Dec 29, 2023 | 42.26B | 70.05% |
| Dec 30, 2022 | 24.85B | -0.36% |
| Dec 30, 2021 | 24.94B | -35.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sawai Group Holdings | 190.84B |
| Towa Pharmaceutical | 180.67B |
| Kissei Pharmaceutical | 164.56B |
| Kaken Pharmaceutical | 143.90B |
| Mochida Pharmaceutical | 112.55B |
| Zeria Pharmaceutical | 90.41B |
| ASKA Pharmaceutical Holdings | 65.96B |
| KYORIN Pharmaceutical | 63.94B |